Skip to content

Clinical trials

Phase 3 Gastroesophageal Reflux trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastroesophageal Reflux Phase: Phase 3 Country / region: Poland Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20064
20072
20091
20111
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda3
Wyeth is now a wholly owned subsidiary of Pfizer3
AstraZeneca1
Cinclus Pharma Holding AB1
Cogentus Pharmaceuticals1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Norgine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastroesophageal Reflux11
Acute Coronary Syndrome1
Cerebrovascular Disorders1
Coronary Artery Disease1
Coronary Thrombosis1
Duodenal Obstruction1
Duodenal Ulcer1
Dyspepsia1
Esophagitis, Peptic1
Gastric Outlet Obstruction1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.